SE9000532L - Farmaceutisk tclf-komposition - Google Patents
Farmaceutisk tclf-kompositionInfo
- Publication number
- SE9000532L SE9000532L SE9000532A SE9000532A SE9000532L SE 9000532 L SE9000532 L SE 9000532L SE 9000532 A SE9000532 A SE 9000532A SE 9000532 A SE9000532 A SE 9000532A SE 9000532 L SE9000532 L SE 9000532L
- Authority
- SE
- Sweden
- Prior art keywords
- human
- tclf
- ebv
- cell lines
- human cell
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/525—Tumour necrosis factor [TNF]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/808—Materials and products related to genetic engineering or hybrid or fused cell technology, e.g. hybridoma, monoclonal products
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Toxicology (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP56112914A JPS5815921A (ja) | 1981-07-21 | 1981-07-21 | 抗リンホトキシン感受性疾患剤 |
JP56112913A JPS5816687A (ja) | 1981-07-21 | 1981-07-21 | リンホトキシンの製造方法 |
JP56120459A JPS5821621A (ja) | 1981-07-31 | 1981-07-31 | ヒトツモア・ネクロシス・ファクタ−を含有する悪性腫瘍治療剤 |
JP56187627A JPH0764744B2 (ja) | 1981-11-21 | 1981-11-21 | 標的細胞障害性因子とヒトインタ−フェロンとを有効成分として含有する悪性腫瘍治療剤 |
JP56187626A JPS5889195A (ja) | 1981-11-21 | 1981-11-21 | 標的細胞障害性因子の製造方法 |
JP56205115A JPS6011890B2 (ja) | 1981-12-21 | 1981-12-21 | ツモアネクロシスフアクタ−の製造方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
SE9000532D0 SE9000532D0 (sv) | 1990-02-14 |
SE9000532L true SE9000532L (sv) | 1991-08-15 |
Family
ID=27552385
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE8204382A SE8204382L (sv) | 1981-07-21 | 1982-07-19 | Sett att framstella malcellysfaktor och anvendning derav |
SE9000532A SE9000532L (sv) | 1981-07-21 | 1990-02-14 | Farmaceutisk tclf-komposition |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE8204382A SE8204382L (sv) | 1981-07-21 | 1982-07-19 | Sett att framstella malcellysfaktor och anvendning derav |
Country Status (9)
Country | Link |
---|---|
US (1) | US4495282A (sv) |
AT (1) | AT387980B (sv) |
AU (1) | AU560793B2 (sv) |
CH (1) | CH664974A5 (sv) |
DE (1) | DE3227262C3 (sv) |
FR (1) | FR2513124B1 (sv) |
GB (1) | GB2106117B (sv) |
IT (1) | IT1196549B (sv) |
SE (2) | SE8204382L (sv) |
Families Citing this family (54)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5821621A (ja) * | 1981-07-31 | 1983-02-08 | Hayashibara Biochem Lab Inc | ヒトツモア・ネクロシス・ファクタ−を含有する悪性腫瘍治療剤 |
US4920196A (en) * | 1982-07-30 | 1990-04-24 | Genentech, Inc. | Human lymphotoxin |
US4806471A (en) * | 1982-09-16 | 1989-02-21 | A/S Alfred Benzon | Plasmids with conditional uncontrolled replication behavior |
IL71954A0 (en) * | 1983-06-01 | 1984-09-30 | Genentech Inc | Gamma interferon-lymphotoxin synergism |
CA1265444A (en) * | 1983-06-27 | 1990-02-06 | Lloyd J. Old | Effect of human tumor necrosis factor and human interferon on human cancer cells and methods |
JPS6019720A (ja) * | 1983-07-14 | 1985-01-31 | Yamanouchi Pharmaceut Co Ltd | ヒト内来性癌制御因子およびその製造法 |
JPS60112718A (ja) * | 1983-11-21 | 1985-06-19 | Kyorin Pharmaceut Co Ltd | 抗腫瘍作用を示す蛋白性物質及びその製造方法 |
EP0147689B1 (en) * | 1983-12-05 | 1990-09-19 | Asahi Kasei Kogyo Kabushiki Kaisha | A method of inducing antitumor immunocytes, and a process for producing antitumor immunocytes and antitumor immunocytes produced by the process |
HU192254B (en) * | 1983-12-13 | 1987-05-28 | Egyt Gyogyszervegyeszeti Gyar | Process for producing human leucocite and human gamma interferons in consecutive steps |
US4758549A (en) * | 1983-12-13 | 1988-07-19 | Kabushiki Kaisha Mayashibara Seibutsu Kagaku Kenkyujo | Lymphokine, monoclonal antibody specific to the lymphokine and their production and uses |
US5288852A (en) * | 1984-03-06 | 1994-02-22 | Dainippon Pharmaceutical Co., Ltd. | Human tumor necrosis factor polypeptides |
US4879226A (en) * | 1984-04-06 | 1989-11-07 | Asahi Kasei Kogyo Kabushiki Kaisha | Novel human physiologically active polypeptide |
JPS60243018A (ja) * | 1984-05-17 | 1985-12-03 | Yamanouchi Pharmaceut Co Ltd | ヒト内来性癌制御因子 |
US5683688A (en) * | 1984-05-31 | 1997-11-04 | Genentech, Inc. | Unglycosylated recombinant human lymphotoxin polypeptides and compositions |
DE3423234A1 (de) * | 1984-06-23 | 1986-02-06 | Boehringer Ingelheim International GmbH, 6507 Ingelheim | Synergistische mischungen von interferonen und tumor-nekrose-faktor |
US5672347A (en) * | 1984-07-05 | 1997-09-30 | Genentech, Inc. | Tumor necrosis factor antagonists and their use |
US6686455B1 (en) | 1984-07-05 | 2004-02-03 | Genentech, Inc. | Tumor necrosis factor |
JPS6124520A (ja) * | 1984-07-12 | 1986-02-03 | Takeshi Makitsubo | 腫瘍壊死因子様物質を抽出する方法 |
GB2161813B (en) * | 1984-07-20 | 1988-07-13 | Michiko Koga | Anti-tumor agent |
US5840522A (en) * | 1984-09-20 | 1998-11-24 | Chiron Corporation | Recombinant lectins |
US4677064A (en) * | 1984-11-09 | 1987-06-30 | Cetus Corporation | Human tumor necrosis factor |
US4677063A (en) * | 1985-05-02 | 1987-06-30 | Cetus Corporation | Human tumor necrosis factor |
US4752575A (en) * | 1984-11-26 | 1988-06-21 | The Regents Of The University Of California | Lymphotoxins with antitumor activity and method for producing same |
EP0216786B1 (en) * | 1984-12-21 | 1992-03-18 | Biogen, Inc. | Purification, production and use of tumor necrosis factors |
PT81823B (pt) * | 1985-01-14 | 1987-11-30 | Yamanouchi Pharma Co Ltd | Metodo de preparacao de factores endogenos humanos reguladores de cancro |
EP0216934A4 (en) * | 1985-03-04 | 1987-07-09 | Sawai Seiyaku Kk | NOVEL SUBSTANCE INDUCING TUMOR NECROSIC FACTOR FROM ACID RESISTANT BACTERIA. |
US6084073A (en) * | 1985-03-25 | 2000-07-04 | Chiron Corporation | Recombinant ricin toxin |
US4770995A (en) * | 1985-08-29 | 1988-09-13 | New York Blood Center, Inc | Detection of the sensitivity of cells to the effects of tumor necrosis factor and lymphotoxin |
US4870163A (en) * | 1985-08-29 | 1989-09-26 | New York Blood Center, Inc. | Preparation of pure human tumor necrosis factor and hybridomas producing monoclonal antibodies to human tumor necrosis factor |
US4677197A (en) * | 1985-10-30 | 1987-06-30 | Cetus Corporation | Purification method for tumor necrosis factor |
US4894439A (en) * | 1986-05-22 | 1990-01-16 | Cetus Corporation | N-terminal derivatives of tumor necrosis factor purified by microporous PTFE membranes |
NZ219027A (en) * | 1986-01-24 | 1989-09-27 | Genentech Inc | Antiviral composition containing interferon tumour necrosis factor and/or lymphotoxin |
US4828830A (en) * | 1986-01-24 | 1989-05-09 | Genentech, Inc. | Method and composition for prophylaxis and treatment of viral infections |
US4822605A (en) * | 1986-02-18 | 1989-04-18 | Exovir, Inc. | Compositions and methods employing the same for the treatment of viral and cancerous skin lesions and the like |
US4777242A (en) * | 1986-10-10 | 1988-10-11 | Phillips Petroleum Company | Purification of recombinant tumor necrosis factor |
US5213970A (en) * | 1987-01-23 | 1993-05-25 | Board Of Regents, The University Of Texas System | Method for obtaining soluble antitumor factor |
US4975377A (en) * | 1987-05-14 | 1990-12-04 | Key Marc E | Cell growth chambers and method of use thereof |
DE3731255A1 (de) * | 1987-09-17 | 1989-04-06 | Boehringer Ingelheim Int | Stabilisierung von therapeutisch wirksamen proteinen in pharmazeutischen zubereitungen |
JPH03501620A (ja) * | 1988-07-15 | 1991-04-11 | ザ・トラステイーズ・オブ・コロンビア・ユニヴアーシテイ・イン・ザ・シテイ・オブ・ニユー・ヨーク | 腫瘍壊死増強因子並びに製造及び使用の方法 |
US6617171B2 (en) * | 1998-02-27 | 2003-09-09 | The General Hospital Corporation | Methods for diagnosing and treating autoimmune disease |
US6599710B1 (en) | 1999-03-10 | 2003-07-29 | The General Hospital Corporation | Treatment of autoimmune disease |
JP4177604B2 (ja) * | 2002-03-25 | 2008-11-05 | 株式会社林原生物化学研究所 | 生理活性複合体 |
US7179891B2 (en) | 2002-03-25 | 2007-02-20 | Tadanori Mayumi | Physiologically active complex |
US7628988B2 (en) * | 2002-06-27 | 2009-12-08 | The General Hospital Corporation | Methods and compositions for treating type 1 diabetes |
US7582313B2 (en) | 2002-06-27 | 2009-09-01 | The General Hospital Corporation | Methods of organ regeneration using Hox 11-expressing pluripotent cells |
US20040229785A1 (en) * | 2002-11-15 | 2004-11-18 | Denise Faustman | Screening methods to identify treatments for autoimmune disease |
DE60333228D1 (de) * | 2002-12-02 | 2010-08-12 | Amgen Fremont Inc | Gegen den tumor nekrose faktor gerichtete antikörper und deren verwendungen |
US20080102054A1 (en) * | 2005-01-18 | 2008-05-01 | Faustman Denise L | Compositions Containing Agm Cells And Methods Of Use Thereof |
EP2953634B1 (en) | 2013-02-07 | 2021-05-26 | The General Hospital Corporation | Methods for expansion or depletion of t-regulatory cells |
US10436680B2 (en) | 2013-10-15 | 2019-10-08 | Kianoosh Peyvan | Capture, disruption, and extraction apparatus and method |
EP3447075B1 (en) | 2015-05-15 | 2023-08-09 | The General Hospital Corporation | Antagonistic anti-tumor necrosis factor receptor superfamily antibodies |
US11266730B2 (en) | 2015-09-29 | 2022-03-08 | The General Hospital Corporation | Methods of treating and diagnosing disease using biomarkers for BCG therapy |
AU2017263833B2 (en) | 2016-05-13 | 2023-08-03 | The General Hospital Corporation | Antagonistic anti-tumor necrosis factor receptor superfamily antibodies |
CN108576399A (zh) * | 2018-03-22 | 2018-09-28 | 中国农业科学院生物技术研究所 | 复合干扰素组合物及其制剂和应用 |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2016015B (en) * | 1978-01-22 | 1982-05-06 | Hayashibara Co | Method of preparing interferon and preparations containing interferon |
EP0005476B1 (de) * | 1978-05-17 | 1981-12-30 | Dr. Karl Thomae GmbH | Verfahren zur Herstellung von Humaninterferon |
JPS5598118A (en) * | 1979-01-18 | 1980-07-25 | Hayashibara Takeshi | Preparation of type-2 interferon and drug containing the same |
JPS55154919A (en) * | 1979-05-24 | 1980-12-02 | Hayashibara Takeshi | Preparation of interferon |
US4328207A (en) * | 1979-12-27 | 1982-05-04 | Ken Hayashibara | Process for preparing mouse interferon |
JPS586475B2 (ja) * | 1980-08-23 | 1983-02-04 | 株式会社 林原生物化学研究所 | ヒト絨毛性性腺刺激ホルモンの製造方法 |
JPS6045849B2 (ja) * | 1980-08-25 | 1985-10-12 | 林原 健 | ヒトエリトロポエチンの製造方法 |
JPS5743696A (en) * | 1980-08-27 | 1982-03-11 | Hayashibara Biochem Lab Inc | Preparation of human luteinizing hormone |
JPS585671B2 (ja) * | 1980-08-27 | 1983-02-01 | 株式会社 林原生物化学研究所 | ヒト卵胞刺激ホルモンの製造方法 |
-
1982
- 1982-07-19 FR FR8212541A patent/FR2513124B1/fr not_active Expired
- 1982-07-19 SE SE8204382A patent/SE8204382L/sv not_active Application Discontinuation
- 1982-07-20 CH CH4420/82A patent/CH664974A5/fr not_active IP Right Cessation
- 1982-07-20 AU AU86200/82A patent/AU560793B2/en not_active Ceased
- 1982-07-20 IT IT48855/82A patent/IT1196549B/it active
- 1982-07-21 AT AT0283582A patent/AT387980B/de active
- 1982-07-21 US US06/400,487 patent/US4495282A/en not_active Expired - Lifetime
- 1982-07-21 GB GB08221100A patent/GB2106117B/en not_active Expired
- 1982-07-21 DE DE3227262A patent/DE3227262C3/de not_active Expired - Lifetime
-
1990
- 1990-02-14 SE SE9000532A patent/SE9000532L/sv not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
DE3227262C3 (de) | 1996-03-21 |
IT8248855A0 (it) | 1982-07-20 |
DE3227262C2 (sv) | 1988-11-17 |
AT387980B (de) | 1989-04-10 |
FR2513124A1 (fr) | 1983-03-25 |
AU8620082A (en) | 1983-01-27 |
FR2513124B1 (fr) | 1989-11-17 |
IT1196549B (it) | 1988-11-16 |
SE8204382L (sv) | 1983-01-22 |
GB2106117A (en) | 1983-04-07 |
SE9000532D0 (sv) | 1990-02-14 |
DE3227262A1 (de) | 1983-03-03 |
SE8204382D0 (sv) | 1982-07-19 |
US4495282A (en) | 1985-01-22 |
GB2106117B (en) | 1985-06-12 |
ATA283582A (de) | 1988-09-15 |
CH664974A5 (fr) | 1988-04-15 |
AU560793B2 (en) | 1987-04-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SE9000532L (sv) | Farmaceutisk tclf-komposition | |
Cheever et al. | Augmentation of the anti-tumor therapeutic efficacy of long-term cultured T lymphocytes by in vivo administration of purified interleukin 2. | |
DE68926859T2 (de) | Natürlicher killerzellen-stimulationsfaktor | |
KR930701601A (ko) | O-글리코실화 ifn-알파 | |
PT93910A (pt) | Prodesso para a preparacao de uma proteina heterologa mediante secrecao a partir de uma celula | |
DE68926971D1 (de) | Klonierte gene, die für elam-1 und für dessen fusionsproteine kodieren sowie die exprimierten proteinprodukte, pharmazeutische zusammensetzungen und deren verwendung | |
US5811523A (en) | Antibodies to natural killer stimulatory factor | |
IT1131325B (it) | Procedimento per ridurre la solubilita' di setacci molecolari zeolitici in un sistema acquoso | |
FI883688A (fi) | Molekylaer kloning och expression av humant interleukin-3. | |
EP0291804A3 (de) | Proteine mit TNF-Wirkung | |
FI945696A0 (sv) | Laktamidipeptider med HLE inhiberande aktivitet | |
ATE64579T1 (de) | Schwimmbadwasserbehandlung. | |
JPS5562024A (en) | Preventive and remedy for interferon-sensitive disease | |
Low et al. | Thymosin and other thymic hormones and their synthetic analogues | |
DE69321121D1 (de) | Fluorenthaltende dipeptide als inhibitoren gegen elastase menschliches leukocyten | |
Murphy et al. | The turnover catabolism and excretion of folate administered at physiological concentrations in the rat | |
ITOH et al. | Purification of a cytotoxic protein produced by the murine macrophage-like cell line J774. 1 in response to Sarcophaga lectin | |
Godard et al. | Preparative two-step purification of human IL-2 by HPLC and hydrophobic affinity chromatography | |
Knudsen et al. | Elevated intracellular cAMP levels inhibit interleukin-1 production by the tumour cell line U937 | |
ATE346921T1 (de) | Menschliches, durch kalzium aktivierbares kaliumkanalpolypeptid aus leukozyten | |
FI914160A0 (fi) | Analysis och behandling av auto- immuniska sjukdomar. | |
Geczy | Characterization of guinea pig mitogenic factors—II: A comparison of some biochemical parameters of mitogen-induced and antigen-induced factors | |
GR3006212T3 (sv) | ||
Einhorn et al. | In vivo administration of interferon to man: studies on the immune system | |
JPS5632421A (en) | Fractionation of plasma protein |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
NAV | Patent application has lapsed |
Ref document number: 9000532-3 |